Remote Biotech research and development Jobs · KOL Engagement

Job listings

$242,750–$313,500/yr

  • Provide strategic vision for the clinical research team and generate rigorous evidence to inform Virta's care model and build credibility.
  • Oversee real-world evidence generation from claims and clinical datasets to demonstrate program impact and drive commercial growth.
  • Build KOL networks, communicate science, and partner with marketing to translate outcomes into compelling market narratives.

Virta Health is on a mission to reverse metabolic disease in one billion people through innovations in technology, personalized nutrition, and virtual care. The company has raised over $350 million from top-tier investors and partners with the largest health plans and employers.

$290,000–$350,000/yr

  • Define and drive the global medical affairs strategy across investigational and marketed products in a fast-growing biotech environment.
  • Build, lead, and scale the global medical affairs organization, including hiring, mentoring, and developing high-performing teams.
  • Provide strategic medical leadership to cross-functional teams and oversee clinical research, publication strategy, and scientific communications.

Our partner is a rapidly growing biotech organization. They operate in a highly dynamic and entrepreneurial environment, balancing long-term vision with urgent execution.

  • Serve as a field-based scientific expert engaging with healthcare professionals and key opinion leaders on autoimmune diseases and cell therapy.
  • Develop and execute territory-specific Medical Affairs and KOL engagement plans aligned with therapeutic area objectives.
  • Collaborate with Clinical Development and Clinical Operations to support company-sponsored clinical trials and scientific dialogue.

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. The company is guided by core values such as 'Stay True to Why' and 'Boldly Innovative', and is committed to transforming treatment for autoimmune disease.